Page last updated: 2024-10-30

losartan and Angiomyolipoma

losartan has been researched along with Angiomyolipoma in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Angiomyolipoma: A benign tumor containing vascular, adipose, and muscle elements. It occurs most often in the kidney with smooth muscle elements (angiolipoleiomyoma) in association with tuberous sclerosis. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"Losartan 50 mg/d was used to control proteinuria under the close watch of serum creatinine."1.51[The 467th case: proteinuria, periungual fibromas, and facial steatadenomas]. ( Chen, G; Dong, QR; Li, MX; Li, XM, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, G1
Dong, QR1
Li, MX1
Li, XM1

Other Studies

1 other study available for losartan and Angiomyolipoma

ArticleYear
[The 467th case: proteinuria, periungual fibromas, and facial steatadenomas].
    Zhonghua nei ke za zhi, 2019, Jan-01, Volume: 58, Issue:1

    Topics: Angiomyolipoma; Apolipoprotein L1; Creatinine; Female; Glomerulonephritis, IGA; Humans; Kidney Failu

2019